A research team has discovered that accumulated DNA damage in the retina is a key contributor to age-related macular degeneration and that targeting specific retinal cell types may lead to treatments ...
It seems Nvidia (NASDAQ: NVDA) is a victim of its own success. Nvidia saw its stock retreat nearly 20% in the weeks following its last release, only to gain nearly 35% from that low. On Tuesday, Dec.